RHINOXAL

Serial Number 97650885
606

Registration Progress

Application Filed
Oct 27, 2022
Under Examination
Nov 14, 2023
Approved for Publication
Sep 19, 2023
Published for Opposition
Sep 19, 2023
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: RHINOXAL
Previous Owner: Orexo AB
Classes: 005

Trademark Image

RHINOXAL

Basic Information

Serial Number
97650885
Filing Date
October 27, 2022
Published for Opposition
September 19, 2023
Abandonment Date
June 17, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 17, 2024
Classes
005

Rights Holder

Orexo AB

03
Address
Virdings allé 32 A
Uppsala SE-75450
SE

Ownership History

Orexo AB

Original Applicant
03
Uppsala SE

Orexo AB

Owner at Publication
03
Uppsala SE

Legal Representation

Attorney
Sarah J. Schneider

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
Jul 12, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 17, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 14, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 19, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 19, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 30, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 10, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 10, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 10, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 31, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medical preparation for use as a narcotic antagonist in the treatment of narcotic overdose; Drug delivery devices, namely, nasal delivery devices sold filled with pharmaceutical preparations for use in the treatment of narcotic overdose; Pharmaceutical preparations in the form of powders for treatment of opioid addiction and overdose

Classification

International Classes
005